OutSee

OutSee is a genomics and drug discovery company utilizing an AI-based predictive genomics approach for target discovery. Their proprietary Nomaly technology predicts disease and phenotype directly from a single genome, offering a unique "genomics first" approach to uncovering biological mechanisms and advancing therapeutic discovery.

Funding Round: Seed

Funding Amount: £1.8M

Date: 24-Jun-2025

Investors: Ahren Innovation Capital, Kadmos Capital, Empirical Ventures, Panacea Ventures

Markets: Genomics, Drug Discovery, AI, Biotechnology Research, Drug Discovery, SaaS, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences

HQ: Cambridge, England, United Kingdom

Founded: 2022

Website: https://outsee.co.uk/

LinkedIn: https://www.linkedin.com/company/outseebio

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/outsee

Pitchbook: https://pitchbook.com/profiles/company/552593-44